Valsartan Tablet
Product Images NDC 43547-367

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 43547-367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\ra\desktop\untitled.jpg (Ee945890 Figure 01)

FDA Label Image

C:\users\ra\desktop\untitled.jpg (Ee945890 Figure 02)

C:\users\ra\desktop\untitled.jpg (Ee945890 Figure 02)
This appears to be a table showing patient subgroups and percentages related to a comparison study between Valsartan and Captopril. The subgroups include age, gender, ethnicity, and country of origin. There is also mention of the usage of beta-blockers during the study. The percentages seem to show a comparison between the two medications, with indications of which medication is in favor.*
FDA Label Image

C:\users\ra\pictures\1.jpg (Ee945890 Figure 03)

FDA Label Image

C:\users\ra\pictures\2.jpg (Ee945890 Figure 04)

FDA Label Image

C:\users\ra\pictures\3.jpg (Ee945890 Figure 05)

FDA Label Image

C:\users\ra\pictures\4.png (Ee945890 Figure 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.